These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 33651487)

  • 1. Integrated analysis of the prognostic values of RNA-binding proteins in head and neck squamous cell carcinoma.
    Wu ZH; Yue JX; Zhou T; Xiao HJ
    Biofactors; 2021 May; 47(3):478-488. PubMed ID: 33651487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive Analysis of the Roles and Prognostic Value of RNA-Binding Proteins in Head and Neck Squamous Cell Carcinoma.
    Jin Y; Qin X
    DNA Cell Biol; 2020 Oct; 39(10):1789-1798. PubMed ID: 32716650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and validation of a RNA binding protein-associated prognostic model for head and neck squamous cell carcinoma.
    Yang X; Han B; Zhang R; Su Y; Hosseini DK; Wu H; Yang M; Sun H
    Aging (Albany NY); 2021 Mar; 13(6):7975-7997. PubMed ID: 33758106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive analysis of the functions, prognostic and diagnostic values of RNA binding proteins in head and neck squamous cell carcinoma.
    Liu H; Ye Z; Wang X; Wu Y; Deng C
    J Stomatol Oral Maxillofac Surg; 2024 Sep; 125(4S):101937. PubMed ID: 38844022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RNA N6-methyladenosine reader IGF2BP2 promotes lymphatic metastasis and epithelial-mesenchymal transition of head and neck squamous carcinoma cells via stabilizing slug mRNA in an m6A-dependent manner.
    Yu D; Pan M; Li Y; Lu T; Wang Z; Liu C; Hu G
    J Exp Clin Cancer Res; 2022 Jan; 41(1):6. PubMed ID: 34980207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification and analysis of genes associated with head and neck squamous cell carcinoma by integrated bioinformatics methods.
    Jin Y; Yang Y
    Mol Genet Genomic Med; 2019 Aug; 7(8):e857. PubMed ID: 31304688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrated analysis of the functions and prognostic values of RNA binding proteins in hepatocellular carcinoma.
    Wu ZH; Huang HM; Yang DL
    BMC Gastroenterol; 2021 Jun; 21(1):265. PubMed ID: 34130650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High eukaryotic initiation factor 5A2 expression predicts poor prognosis and may participate in the SNHG16/miR-10b-5p/EIF5A2 regulatory axis in head and neck squamous cell carcinoma.
    Ye S; Wang D; Jin M; Du J; Chen X; Zhang H; Zhou C; Fang S; Liu K
    J Clin Lab Anal; 2023 Jan; 37(1):e24820. PubMed ID: 36550070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of Potential Biomarkers and Survival Analysis for Head and Neck Squamous Cell Carcinoma Using Bioinformatics Strategy: A Study Based on TCGA and GEO Datasets.
    Shen Y; Liu J; Zhang L; Dong S; Zhang J; Liu Y; Zhou H; Dong W
    Biomed Res Int; 2019; 2019():7376034. PubMed ID: 31485443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene-expression signature regulated by the KEAP1-NRF2-CUL3 axis is associated with a poor prognosis in head and neck squamous cell cancer.
    Namani A; Matiur Rahaman M; Chen M; Tang X
    BMC Cancer; 2018 Jan; 18(1):46. PubMed ID: 29306329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor Mutation Burden, Immune Cell Infiltration, and Construction of Immune-Related Genes Prognostic Model in Head and Neck Cancer.
    Jiang AM; Ren MD; Liu N; Gao H; Wang JJ; Zheng XQ; Fu X; Liang X; Ruan ZP; Tian T; Yao Y
    Int J Med Sci; 2021; 18(1):226-238. PubMed ID: 33390791
    [No Abstract]   [Full Text] [Related]  

  • 12. Identification of enhancer RNAs for the prognosis of head and neck squamous cell carcinoma.
    Feng G; Wang T; Xue F; Qi Y; Wang R; Yuan H
    Head Neck; 2021 Dec; 43(12):3820-3831. PubMed ID: 34569097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of SERPINE1, PLAU and ACTA1 as biomarkers of head and neck squamous cell carcinoma based on integrated bioinformatics analysis.
    Yang K; Zhang S; Zhang D; Tao Q; Zhang T; Liu G; Liu X; Zhao T
    Int J Clin Oncol; 2019 Sep; 24(9):1030-1041. PubMed ID: 30937621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and validation of a fourteen- innate immunity-related gene pairs signature for predicting prognosis head and neck squamous cell carcinoma.
    Zhang F; Liu Y; Yang Y; Yang K
    BMC Cancer; 2020 Oct; 20(1):1015. PubMed ID: 33081731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. KLF7 regulates super-enhancer-driven IGF2BP2 overexpression to promote the progression of head and neck squamous cell carcinoma.
    Cai H; Liang J; Jiang Y; Wang Z; Li H; Wang W; Wang C; Hou J
    J Exp Clin Cancer Res; 2024 Mar; 43(1):69. PubMed ID: 38443991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IGF2BP2 serves as a core m6A regulator in head and neck squamous cell carcinoma.
    Hu Y; Chen J; Liu M; Feng Q; Peng H
    Biosci Rep; 2022 Nov; 42(11):. PubMed ID: 36281789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA methylation biomarkers for head and neck squamous cell carcinoma.
    Zhou C; Ye M; Ni S; Li Q; Ye D; Li J; Shen Z; Deng H
    Epigenetics; 2018; 13(4):398-409. PubMed ID: 29927694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcription factors CP2 and YY1 as prognostic markers in head and neck squamous cell carcinoma: analysis of The Cancer Genome Atlas and a second independent cohort.
    Schnoell J; Jank BJ; Kadletz-Wanke L; Stoiber S; Spielvogel CP; Gurnhofer E; Kenner L; Heiduschka G
    J Cancer Res Clin Oncol; 2021 Mar; 147(3):755-765. PubMed ID: 33315124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transfer-RNA-Derived Fragments Are Potential Prognostic Factors in Patients with Squamous Cell Carcinoma of the Head and Neck.
    Gu X; Wang L; Coates PJ; Boldrup L; Fåhraeus R; Wilms T; Sgaramella N; Nylander K
    Genes (Basel); 2020 Nov; 11(11):. PubMed ID: 33202812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High expression of ACTL8 is poor prognosis and accelerates cell progression in head and neck squamous cell carcinoma.
    Li B; Zhu J; Meng L
    Mol Med Rep; 2019 Feb; 19(2):877-884. PubMed ID: 30535476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.